Abbott Laboratories gains attention as medical devices, diabetes care, cardiovascular products, and raised guidance ...
Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...
Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...
Abbott Laboratories (NYSE:ABT) reported second-quarter 2026 comparable sales growth of 4.8% and adjusted earnings per share ...
Abbott Laboratories (NYSE:ABT) operates across healthcare segments while remaining part of the S&P 500 with medical devices, ...
The Abbott Laboratories logo is displayed at the company's booth during the Consumer Electronics Show (CES) on January 5, 2022 in Las Vegas, Nevada. (Photo by Patrick T. FALLON / AFP) (Photo by ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The North Chicago company said ...
6don MSN
Abbott Laboratories Q2 preview: Analysts see healthy growth backed by Exact Sciences acquisition
Abbott Laboratories (ABT) is due to report second-quarter earnings on July 15, with analysts expecting the firm to report healthy top- and bottom-line growth. The firm’s earnings are expected to inch ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results